Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances
Endong Zhang, Philana Phan, Zongmin Zhao
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1789-1827
Open Access | Times Cited: 21

Showing 21 citing articles:

Platelet-derived drug delivery systems: Pioneering treatment for cancer, cardiovascular diseases, infectious diseases, and beyond
Yalan Zhu, Lingling Xu, Yong Kang, et al.
Biomaterials (2024) Vol. 306, pp. 122478-122478
Closed Access | Times Cited: 23
Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung
Tianchuan Zhu, Yuchen Xiao, Zhenxing Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Dendritic Nanomedicine with Boronate Bonds for Augmented Chemo‐Immunotherapy via Synergistic Modulation of Tumor Immune Microenvironment
Yunkun Li, Yahui Wu, Zaixiang Fang, et al.
Advanced Materials (2023) Vol. 36, Iss. 2
Closed Access | Times Cited: 41
Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
Shumin Luo, Jing Chen, Fang Xu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2070-2070
Open Access | Times Cited: 34
Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts
Naushad Ahmad Khan, Mohammad Asim, Kabir H. Biswas, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 21
Immune cell-derived extracellular vesicles for precision therapy of inflammatory-related diseases
Shuo Li, Wenqing Li, Xianggui Wu, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 533-547
Closed Access | Times Cited: 7
Exosomal miR‐181d‐5p Derived from Rapamycin‐Conditioned MDSC Alleviated Allograft Rejection by Targeting KLF6
Chao Wei, Yaru Sun, Fanxing Zeng, et al.
Advanced Science (2023) Vol. 10, Iss. 34
Open Access | Times Cited: 13
M1-polarized macrophage-derived cellular nanovesicle-coated lipid nanoparticles for enhanced cancer treatment through hybridization of gene therapy and cancer immunotherapy
Ha Eun Shin, Jun‐Hyeok Han, Seungyong Shin, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 3169-3183
Open Access | Times Cited: 5
Genetically Engineered Cellular Nanovesicles: Theories, Design and Perspective
Qinzhen Cheng, Runtan Li, Yiling He, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 46
Closed Access | Times Cited: 5
Biomimetic Nanoparticles for Basic Drug Delivery
Andrey Tikhonov, Artyom Kachanov, Alexandra Yudaeva, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1306-1306
Open Access | Times Cited: 4
NK cellular derived nanovesicles in tumor immunity
Dingru Li, Yixin Shi, Sifei Yu, et al.
Molecular Immunology (2025) Vol. 182, pp. 54-61
Open Access
State-of-the-Art of Synthesized Exosomes and NPs-Based Biomimetic Nanoparticles for Wound Rehabilitation: A Review
Eliasu Issaka
Deleted Journal (2023) Vol. 2, Iss. 1, pp. 241-274
Open Access | Times Cited: 9
T-cell immunity against senescence: potential role and perspectives
Kseniia S. Matveeva, M.A. Vasilieva, Ekaterina Minskaia, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Extracellular vesicles and their cells of origin: Open issues in autoimmune diseases
Azadeh Haghighitalab, Massimo Dominici, Maryam Moghaddam Matin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles
Yuxuan Liu, Fuxu Yang, Zhimin Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Cellular-Membrane-Derived Vesicles for Cancer Immunotherapy
Xiaoyu An, Yun Zeng, Chao Liu, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 22-22
Open Access | Times Cited: 6
Exosomes as a potential therapeutic approach in osteoimmunology
Ivan V. Zhivodernikov, Yuliya V. Markina, Tatiana V. Kirichenko, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
EV-out or EV-in: Tackling cell-to-cell communication within the tumor microenvironment to enhance anti-tumor efficacy using extracellular vesicle-based therapeutic strategies
Wararat Chiangjong, Somchai Chutipongtanate
OpenNano (2022) Vol. 8, pp. 100085-100085
Open Access | Times Cited: 8
Dendritic cell-derived exosome (DEX) therapy for digestive system cancers: Recent advances and future prospect
Sulieman Ibraheem Shelash Al-Hawary, Yasir Q. Аlmajidi, Pooja Bansal, et al.
Pathology - Research and Practice (2024) Vol. 257, pp. 155288-155288
Closed Access | Times Cited: 1
The novel insights of epithelial-derived exosomes in various fibrotic diseases
Rifu Wang, Yuxin Shi, Yonglin Lv, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116591-116591
Open Access | Times Cited: 1
Editorial of Special Column on Delivery Nanotechnologies to Modulate the Immune System and Combat Inflammation and Infection
Wei He, Alejandro Sosnik, Chenjie Xu
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 6, pp. 2296-2297
Open Access
Page 1

Scroll to top